This decrease in cell growth is at least partially due to increased cholesterol efflux from CRC cells as a result of increased ABCA1 and ABCG1 expression following menin inhibition, as the phenotype can be recapitulated by treating CRC cells with an LXR-agonist [258]. Here, ABCA1 is linked to colorectal carcinoma.